Placide Okitayemba Welo
Overview
Explore the profile of Placide Okitayemba Welo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
17
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Koyuncu A, Bugeme P, Dent J, Hutchins C, Xu H, Gallandat K, et al.
BMJ Public Health
. 2025 Feb;
3(1):e001035.
PMID: 40017972
Background: We conducted three serial cross-sectional representative surveys after a mass cholera vaccination campaign in Uvira, Democratic Republic of the Congo to (1) estimate the vaccination coverage and explore heterogeneity...
2.
Blake A, Walder A, Hanks E, Welo P, Luquero F, Bompangue D, et al.
PLoS Negl Trop Dis
. 2025 Feb;
19(2):e0012867.
PMID: 39970173
Cholera is a bacterial water-borne diarrheal disease transmitted via the fecal-oral route that causes high morbidity in sub-Saharan Africa and Asia. It is preventable with vaccination, and Water, Sanitation, and...
3.
Briskin E, Bateyi Mustafa S, Mahamba R, Kabunga D, Kubuya J, Porten K, et al.
Vaccine X
. 2024 Sep;
20:100555.
PMID: 39315336
Background: In 2019-2020, preventative Oral Cholera Vaccine campaigns were conducted in 24/32 non-contiguous health areas of Goma, DR Congo. In August 2022, we measured coverage and factors potentially influencing success...
4.
Bugeme P, Xu H, Hutchins C, Dent J, Saidi J, Bashige Rumedeka B, et al.
Open Forum Infect Dis
. 2024 Mar;
11(3):ofae058.
PMID: 38500577
Our understanding of the burden and drivers of cholera mortality is hampered by limited surveillance and confirmation capacity. Leveraging enhanced clinical and laboratory surveillance in the cholera-endemic community of Uvira,...
5.
Ratnayake R, Peyraud N, Ciglenecki I, Gignoux E, Lightowler M, Azman A, et al.
BMJ Open
. 2022 Jul;
12(7):e061206.
PMID: 35793924
Introduction: Cholera outbreaks in fragile settings are prone to rapid expansion. Case-area targeted interventions (CATIs) have been proposed as a rapid and efficient response strategy to halt or substantially reduce...
6.
DMello-Guyett L, Cumming O, Rogers E, Dhondt R, Mengitsu E, Mashako M, et al.
Confl Health
. 2022 Mar;
16(1):12.
PMID: 35351171
Background: Cholera epidemics occur frequently in low-income countries affected by concurrent humanitarian crises. Evaluations of these epidemic response remains largely unpublished and there is a need to generate evidence on...
7.
DMello-Guyett L, Cumming O, Bonneville S, Dhondt R, Mashako M, Nakoka B, et al.
BMJ Open
. 2021 Oct;
11(10):e050943.
PMID: 34649847
Introduction: Household contacts of cholera cases are at a greater risk of infection than the general population. There is currently no agreed standard of care for household contacts, despite their...